Login / Signup

Outcome and molecular measurable residual disease monitoring in adult B-cell acute lymphoblastic leukemia patients with MEF2D fusions.

Kai SunWen-Min ChenXu WangXiao-Su ZhaoLing-Di LiYue HaoJun WangNan XuQian JiangHao JiangLan-Ping XuYu WangXiao-Hui ZhangXiao-Jun HuangYa-Zhen Qin
Published in: Hematological oncology (2022)
N/A This article is protected by copyright. All rights reserved.
Keyphrases
  • acute lymphoblastic leukemia
  • allogeneic hematopoietic stem cell transplantation
  • single molecule
  • childhood cancer
  • acute myeloid leukemia